Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Non-Current Deferred Tax Liability: 2022-2023

Historic Non-Current Deferred Tax Liability for Bicycle Therapeutics (BCYC) over the last 2 years, with Dec 2023 value amounting to $3.4 million.

  • Bicycle Therapeutics' Non-Current Deferred Tax Liability fell 23.10% to $3.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was $3.4 million, marking a year-over-year decrease of 23.10%. This contributed to the annual value of $3.4 million for FY2023, which is 23.10% down from last year.
  • Per Bicycle Therapeutics' latest filing, its Non-Current Deferred Tax Liability stood at $3.4 million for FY2023, which was down 23.10% from $4.4 million recorded in FY2022.
  • Over the past 5 years, Bicycle Therapeutics' Non-Current Deferred Tax Liability peaked at $4.4 million during FY2022, and registered a low of $3.4 million during FY2023.
  • In the last 2 years, Bicycle Therapeutics' Non-Current Deferred Tax Liability had a median value of $3.9 million in 2022 and averaged $3.9 million.
  • Data for Bicycle Therapeutics' Non-Current Deferred Tax Liability shows a maximum YoY dropped of 23.10% (in 2023) over the last 5 years.
  • Over the past 2 years, Bicycle Therapeutics' Non-Current Deferred Tax Liability (Yearly) stood at $4.4 million in 2022, then dropped by 23.10% to $3.4 million in 2023.